Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients

BACKGROUND: The rapid course of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic calls for fast implementation of clinical trials to assess the effects of new treatment and prophylactic interventions. Building trial platforms embedded in existing data infrastructures is an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusejko, Katharina, Chammartin, Frédérique, Smith, Daniel, Odermatt, Marc, Schuhmacher, Julian, Koller, Michael, Günthard, Huldrych F., Briel, Matthias, Bucher, Heiner C., Speich, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330973/
https://www.ncbi.nlm.nih.gov/pubmed/35902817
http://dx.doi.org/10.1186/s12879-022-07621-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330973/
https://www.ncbi.nlm.nih.gov/pubmed/35902817
http://dx.doi.org/10.1186/s12879-022-07621-x

Ejemplares similares